Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy

Elio Mazzone, Francesco A. Mistretta, Sophie Knipper, Zhe Tian, Carlotta Palumbo, Giorgio Gandaglia, Denis Soulieres, Derya Tilki, Francesco Montorsi, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Pierre I. Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

In contemporary stage I nonseminoma germ-cell tumor of the testis (NSGCTT) patients, increasing use of surveillance and chemotherapy, in concordance with guideline recommendations, is evident. Long-term survival rates were comparable between surveillance and active treatment (AT) patients. Among AT, retroperitoneal lymph node dissection was associated with better long-term survival outcomes. These results confirm the contemporary adherence to guideline recommendations and also confirm the safety of surveillance in patients with stage I NSGCTT.

Original languageEnglish
Pages (from-to)e1153-e1162
JournalClinical Genitourinary Cancer
Volume17
Issue number6
DOIs
Publication statusPublished - Dec 2019

Keywords

  • Chemotherapy
  • Retroperitoneal lymph node dissection
  • SEER Program
  • Stage I testicular cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy'. Together they form a unique fingerprint.

Cite this